Trait centric view

1. Trait name:	Intramuscular fat content
   Ontology terms:	VT:0010044, LPT:0000098, CMO:0000208

   111 genes are associated with this trait, with QTL/association found

   • AASS: Aminoadipate-semialdehyde synthase
     evidenced by: QTL:22464;
   • ABLIM1: Actin binding LIM protein 1
     evidenced by: QTL:193553;
   • ABLIM3: Actin binding LIM protein family member 3
     evidenced by: QTL:263280;
   • ACACA: Acetyl-CoA carboxylase alpha
     evidenced by: QTL:193135;
   • ACSL4: Acyl-CoA synthetase long-chain family member 4
     evidenced by: QTL:17874;
   • ADAM22: ADAM metallopeptidase domain 22
     evidenced by: QTL:21962;
   • ADIPOQ: Adiponectin, C1Q and collagen domain containing
     evidenced by: QTL:283415; QTL:285994;
   • AGPAT5: 1-acylglycerol-3-phosphate O-acyltransferase 5
     evidenced by: QTL:261627; QTL:261628;
   • ANK1: Ankyrin 1, erythrocytic
     evidenced by: QTL:12074;
   • ATG2B: Autophagy related 2B
     evidenced by: QTL:169098;
   • ATP5B: ATP synthase, H+ transporting, mitochondrial F1 complex, beta polypeptide
     evidenced by: QTL:24241;
   • ATXN3: Ataxin 3
     evidenced by: QTL:169095; QTL:169096;
   • AVPR1B: Arginine vasopressin receptor 1B
     evidenced by: QTL:24230;
   • BDKRB2: Bradykinin receptor B2
     evidenced by: QTL:176611; QTL:176612;
   • BFAR: Bifunctional apoptosis regulator
     evidenced by: QTL:224708;
   • BMP6: Bone morphogenetic protein 6
     evidenced by: QTL:224720;
   • CA3: Carbonic anhydrase III, muscle specific
     evidenced by: QTL:12100;
   • CAB39L: Calcium binding protein 39 like
     evidenced by: QTL:193545;
   • CASQ2: Calsequestrin 2
     evidenced by: QTL:176602;
   • CAST: Calpastatin
     evidenced by: QTL:17526; QTL:17529; QTL:17532; QTL:17535; QTL:17537; QTL:285998; QTL:31458; QTL:31459; QTL:31485; QTL:31496; QTL:31498; QTL:31501; QTL:31508; QTL:31512; QTL:31515;
   • CCSER1: Coiled-coil serine rich protein 1
     evidenced by: QTL:223172;
   • CDH20: Cadherin 20
     evidenced by: QTL:216358;
   • CLN6: CLN6 transmembrane ER protein
     evidenced by: QTL:216350;
   • CLVS1: Clavesin 1
     evidenced by: QTL:169090;
   • CNTN1: Contactin 1
     evidenced by: QTL:224703;
   • CORO2B: Coronin, actin binding protein, 2B
     evidenced by: QTL:216359;
   • CSDE1: Cold shock domain containing E1
     evidenced by: QTL:193522;
   • CTNND2: Catenin delta 2
     evidenced by: QTL:223184; QTL:223185;
   • CTSS: Cathepsin S
     evidenced by: QTL:315810;
   • CYRIA: CYFIP related Rac1 interactor A
     evidenced by: QTL:223159;
   • DIO3: Deiodinase, iodothyronine, type III
     evidenced by: QTL:17888;
   • DLG2: Discs large MAGUK scaffold protein 2
     evidenced by: QTL:193530;
   • DLGAP5: Discs, large (Drosophila) homolog-associated protein 5
     evidenced by: QTL:21960;
   • DNAH2: Dynein, axonemal, heavy chain 2
     evidenced by: QTL:37673;
   • DPT: Dermatopontin
     evidenced by: QTL:169091;
   • DRD3: Dopamine receptor D3
     evidenced by: QTL:24223;
   • EPOR: Erythropoietin receptor
     evidenced by: QTL:12105;
   • FABP1: Fatty acid binding protein 1, liver
     evidenced by: QTL:65347;
   • FABP3: Fatty acid binding protein 3, muscle and heart (mammary-derived growth inhibitor)
     evidenced by: QTL:10601; QTL:17344; QTL:17345; QTL:213563; QTL:4165;
   • FABP3: Fatty acid binding protein 3, muscle and heart
     evidenced by: QTL:65391; QTL:65392;
   • FABP4: Fatty acid binding protein 4, adipocyte
     evidenced by: QTL:18034; QTL:639;
   • FADS2: Fatty acid desaturase 2
     evidenced by: QTL:31554;
   • FAF1: Fas associated factor 1
     evidenced by: QTL:176607;
   • FAM132A: Family with sequence similarity 132, member A
     evidenced by: QTL:22453;
   • FASN: Fatty acid synthase
     evidenced by: QTL:125089; QTL:172584;
   • FAT3: FAT atypical cadherin 3
     evidenced by: QTL:193533; QTL:193534; QTL:193535; QTL:193536; QTL:193537; QTL:193538;
   • FFAR3: Free fatty acid receptor 3
     evidenced by: QTL:22452;
   • FTO: Fat mass and obesity associated
     evidenced by: QTL:12124; QTL:32783; QTL:32784;
   • GET4: Guided entry of tail-anchored proteins factor 4
     evidenced by: QTL:176598;
   • GLP2R: Glucagon-like peptide 2 receptor
     evidenced by: QTL:37679;
   • GPC6: Glypican 6
     evidenced by: QTL:223176;
   • GPIHBP1: Glycosylphosphatidylinositol anchored high density lipoprotein binding protein 1
     evidenced by: QTL:65393; QTL:65394;
   • GYPC: Glycophorin C
     evidenced by: QTL:223183;
   • ICK: Intestinal cell (MAK-like) kinase
     evidenced by: QTL:169100;
   • IL6: Interleukin 6
     evidenced by: QTL:237646;
   • INPP5K: Inositol polyphosphate-5-phosphatase K
     evidenced by: QTL:23987;
   • JPH1: Junctophilin 1
     evidenced by: QTL:169089;
   • KDSR: 3-ketodihydrosphingosine reductase
     evidenced by: QTL:216355;
   • KIRREL1: Kirre like nephrin family adhesion molecule 1
     evidenced by: QTL:169092;
   • LCLAT1: Lysocardiolipin acyltransferase 1
     evidenced by: QTL:22438; QTL:22439;
   • LEPR: Leptin receptor
     evidenced by: QTL:106316; QTL:106318; QTL:12059; QTL:23098; QTL:261642; QTL:296744;
   • LOC100511657: Serine/threonine-protein kinase NLK
     evidenced by: QTL:106199; QTL:106201;
   • MAOA: Monoamine oxidase A
     evidenced by: QTL:24216; QTL:24217;
   • MC4R: Melanocortin 4 receptor
     evidenced by: QTL:216362;
   • MYH4: Myosin, heavy chain 4, skeletal muscle
     evidenced by: QTL:37683;
   • NCOA2: Nuclear receptor coactivator 2
     evidenced by: QTL:22442; QTL:22443;
   • NDEL1: NudE nuclear distribution E homolog (A. nidulans)-like 1
     evidenced by: QTL:37674;
   • NEDD4L: Neural precursor cell expressed, developmentally down-regulated 4-like, E3 ubiquitin protein ligase
     evidenced by: QTL:169088;
   • NR0B2: Nuclear receptor subfamily 0, group B, member 2
     evidenced by: QTL:10602;
   • NRXN3: Neurexin 3
     evidenced by: QTL:223167;
   • PAQR5: Progestin and adipoQ receptor family member 5
     evidenced by: QTL:216366;
   • PDLIM5: PDZ and LIM domain 5
     evidenced by: QTL:21961;
   • PDZRN4: PDZ domain containing ring finger 4
     evidenced by: QTL:224712; QTL:224713;
   • PHACTR1: Phosphatase and actin regulator 1
     evidenced by: QTL:223667;
   • PHKG: Phosphorylase kinase gamma subunit
     evidenced by: QTL:37555;
   • PIK3C3: Phosphatidylinositol 3-kinase, catalytic subunit type 3
     evidenced by: QTL:17634;
   • PIK3R5: Phosphoinositide-3-kinase, regulatory subunit 5
     evidenced by: QTL:37676;
   • PIK3R6: Phosphoinositide-3-kinase, regulatory subunit 6
     evidenced by: QTL:37675;
   • PPARA: Peroxisome proliferator-activated receptor alpha
     evidenced by: QTL:31318;
   • PPHLN1: Periphilin 1
     evidenced by: QTL:224716;
   • PRKAG3: Protein kinase, AMP-activated, gamma 3 non-catalytic subunit
     evidenced by: QTL:23995; QTL:24002; QTL:24010; QTL:24012;
   • PSD3: Pleckstrin and Sec7 domain containing 3
     evidenced by: QTL:223187;
   • RETN: Resistin
     evidenced by: QTL:65995;
   • RNF115: Ring finger protein 115
     evidenced by: QTL:176601;
   • RNF152: Ring finger protein 152
     evidenced by: QTL:216360;
   • RORC: RAR-related orphan receptor C
     evidenced by: QTL:22447;
   • ROS1: ROS proto-oncogene 1, receptor tyrosine kinase
     evidenced by: QTL:176595;
   • RPL31: Ribosomal protein L31
     evidenced by: QTL:224719;
   • RYR1: Ryanodine receptor 1 (skeletal)
     evidenced by: QTL:213564;
   • SAMD4A: Sterile alpha motif domain containing 4A
     evidenced by: QTL:169087;
   • SCD: Stearoyl-CoA desaturase (delta-9-desaturase)
     evidenced by: QTL:193140; QTL:213565; QTL:31537;
   • SCN3A: Sodium voltage-gated channel alpha subunit 3
     evidenced by: QTL:224711;
   • SDAD1: SDA1 domain containing 1
     evidenced by: QTL:169104;
   • SFXN4: Sideroflexin 4
     evidenced by: QTL:238769;
   • SHISAL1: Shisa like 1
     evidenced by: QTL:176605;
   • SLC13A5: Solute carrier family 13 (sodium-dependent citrate transporter), member 5
     evidenced by: QTL:37670;
   • SLC24A4: Solute carrier family 24 member 4
     evidenced by: QTL:169097;
   • SLC2A13: Solute carrier family 2 member 13
     evidenced by: QTL:224704; QTL:224706; QTL:224714; QTL:224715; QTL:224718;
   • SLC38A11: Solute carrier family 38 member 11
     evidenced by: QTL:224710;
   • SLC9A7: Solute carrier family 9, subfamily A (NHE7, cation proton antiporter 7), member 7
     evidenced by: QTL:21958;
   • SNAI2: Snail homolog 2 (Drosophila)
     evidenced by: QTL:22444;
   • TFAP2B: Transcription factor AP-2 beta (activating enhancer binding protein 2 beta)
     evidenced by: QTL:22455; QTL:22456;
   • TIAM1: T cell lymphoma invasion and metastasis 1
     evidenced by: QTL:176617; QTL:223180;
   • TMEM138: Transmembrane protein 138
     evidenced by: QTL:176596;
   • TMEM220: Transmembrane protein 220
     evidenced by: QTL:21957;
   • UBE3C: Ubiquitin-protein ligase E3C
     evidenced by: QTL:122509;
   • UNC-6: Netrin-1
     evidenced by: QTL:37677;
   • UNC79: N/aunc-79 homolog, NALCN channel complex subunit
     evidenced by: QTL:223168;
   • USP43: Ubiquitin specific peptidase 43
     evidenced by: QTL:37678;
   • VRTN: Vertebrae development homolog (pig)
     evidenced by: QTL:24092; QTL:24093;
   • ZDHHC2: Zinc finger DHHC-type palmitoyltransferase 2
     evidenced by: QTL:193559;
   453 correlations are found involving Intramuscular fat content